Biochemical recurrence after radical prostatectomy

Current status of its use as a treatment endpoint and early management strategies

Barrett McCormick, Ali Mahmoud, Stephen Williams, John Davis

    Research output: Contribution to journalReview article

    1 Citation (Scopus)

    Abstract

    Prostate cancer is one of the most common urological malignancies managed by a practicing urologist. Treatment strategies are varied, but radical prostatectomy (RP) remains a viable and commonly used option for many patients. A continuing challenge in the management is how to approach a patient who has biochemical recurrence (BCR) after RP. There are no consensus guidelines on the appropriate strategy, and the current recommendations, although useful, are at times confusing. The natural history of BCR is heterogeneous. Published studies aid in the clinician's ability to predict patients most likely to recur; however, this remains inexact. In addition, recent changes in the recommendations for disease screening, as well as technological advances, have added to the already challenging task of the clinician. The objective of this review is to provide an up-to-date summary of the definitions, diagnosis, and management strategies of BCR after RP. This narrative review was conducted by searching Medline for all relevant articles in English with the key terms of biochemical recurrence, prostate cancer, management, and other relevant terms. Information was compiled and reviewed for relevance to the article. Consideration was given to all articles with sufficient evidence including systematic review, retrospective studies, and clinical trials.

    Original languageEnglish (US)
    Pages (from-to)6-17
    Number of pages12
    JournalIndian Journal of Urology
    Volume35
    Issue number1
    DOIs
    StatePublished - Jan 1 2019

    Fingerprint

    Prostatectomy
    Recurrence
    Prostatic Neoplasms
    Therapeutics
    Natural History
    Retrospective Studies
    Clinical Trials
    Guidelines
    Neoplasms

    ASJC Scopus subject areas

    • Urology

    Cite this

    Biochemical recurrence after radical prostatectomy : Current status of its use as a treatment endpoint and early management strategies. / McCormick, Barrett; Mahmoud, Ali; Williams, Stephen; Davis, John.

    In: Indian Journal of Urology, Vol. 35, No. 1, 01.01.2019, p. 6-17.

    Research output: Contribution to journalReview article

    @article{8a1ff386e7b441a2ab12a41c04a28d17,
    title = "Biochemical recurrence after radical prostatectomy: Current status of its use as a treatment endpoint and early management strategies",
    abstract = "Prostate cancer is one of the most common urological malignancies managed by a practicing urologist. Treatment strategies are varied, but radical prostatectomy (RP) remains a viable and commonly used option for many patients. A continuing challenge in the management is how to approach a patient who has biochemical recurrence (BCR) after RP. There are no consensus guidelines on the appropriate strategy, and the current recommendations, although useful, are at times confusing. The natural history of BCR is heterogeneous. Published studies aid in the clinician's ability to predict patients most likely to recur; however, this remains inexact. In addition, recent changes in the recommendations for disease screening, as well as technological advances, have added to the already challenging task of the clinician. The objective of this review is to provide an up-to-date summary of the definitions, diagnosis, and management strategies of BCR after RP. This narrative review was conducted by searching Medline for all relevant articles in English with the key terms of biochemical recurrence, prostate cancer, management, and other relevant terms. Information was compiled and reviewed for relevance to the article. Consideration was given to all articles with sufficient evidence including systematic review, retrospective studies, and clinical trials.",
    author = "Barrett McCormick and Ali Mahmoud and Stephen Williams and John Davis",
    year = "2019",
    month = "1",
    day = "1",
    doi = "10.4103/iju.IJU_355_18",
    language = "English (US)",
    volume = "35",
    pages = "6--17",
    journal = "Indian Journal of Urology",
    issn = "0970-1591",
    publisher = "Medknow Publications and Media Pvt. Ltd",
    number = "1",

    }

    TY - JOUR

    T1 - Biochemical recurrence after radical prostatectomy

    T2 - Current status of its use as a treatment endpoint and early management strategies

    AU - McCormick, Barrett

    AU - Mahmoud, Ali

    AU - Williams, Stephen

    AU - Davis, John

    PY - 2019/1/1

    Y1 - 2019/1/1

    N2 - Prostate cancer is one of the most common urological malignancies managed by a practicing urologist. Treatment strategies are varied, but radical prostatectomy (RP) remains a viable and commonly used option for many patients. A continuing challenge in the management is how to approach a patient who has biochemical recurrence (BCR) after RP. There are no consensus guidelines on the appropriate strategy, and the current recommendations, although useful, are at times confusing. The natural history of BCR is heterogeneous. Published studies aid in the clinician's ability to predict patients most likely to recur; however, this remains inexact. In addition, recent changes in the recommendations for disease screening, as well as technological advances, have added to the already challenging task of the clinician. The objective of this review is to provide an up-to-date summary of the definitions, diagnosis, and management strategies of BCR after RP. This narrative review was conducted by searching Medline for all relevant articles in English with the key terms of biochemical recurrence, prostate cancer, management, and other relevant terms. Information was compiled and reviewed for relevance to the article. Consideration was given to all articles with sufficient evidence including systematic review, retrospective studies, and clinical trials.

    AB - Prostate cancer is one of the most common urological malignancies managed by a practicing urologist. Treatment strategies are varied, but radical prostatectomy (RP) remains a viable and commonly used option for many patients. A continuing challenge in the management is how to approach a patient who has biochemical recurrence (BCR) after RP. There are no consensus guidelines on the appropriate strategy, and the current recommendations, although useful, are at times confusing. The natural history of BCR is heterogeneous. Published studies aid in the clinician's ability to predict patients most likely to recur; however, this remains inexact. In addition, recent changes in the recommendations for disease screening, as well as technological advances, have added to the already challenging task of the clinician. The objective of this review is to provide an up-to-date summary of the definitions, diagnosis, and management strategies of BCR after RP. This narrative review was conducted by searching Medline for all relevant articles in English with the key terms of biochemical recurrence, prostate cancer, management, and other relevant terms. Information was compiled and reviewed for relevance to the article. Consideration was given to all articles with sufficient evidence including systematic review, retrospective studies, and clinical trials.

    UR - http://www.scopus.com/inward/record.url?scp=85059848367&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85059848367&partnerID=8YFLogxK

    U2 - 10.4103/iju.IJU_355_18

    DO - 10.4103/iju.IJU_355_18

    M3 - Review article

    VL - 35

    SP - 6

    EP - 17

    JO - Indian Journal of Urology

    JF - Indian Journal of Urology

    SN - 0970-1591

    IS - 1

    ER -